Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction

International Journal of Impotence Research

Volumn 10, Issue 4, 1998, Pages 211-214

  Ghanem, T ^a,b   Sherif, ^c   Abdel Gawad, T ^d,e   Asaad, T ^b,f  

^a CAIRO UNIVERSITY   (Egypt)

^b Dr Erfan and Bagedo General Hospital   (Saudi Arabia)

^c KING KHALID HOSPITAL   (Saudi Arabia)

^d CAIRO UNIVERSITY   (Egypt)

^e DR SOLIMAN FAKEEH HOSPITAL   (Saudi Arabia)

^f AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Erectile dysfunction; Impotence; Intracavernous injection; Pharmacological erections

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1; VASOACTIVE AGENT;

ARTICLE; CLINICAL TRIAL; DRUG SELF ADMINISTRATION; ERECTILE DYSFUNCTION; HUMAN; INJECTION PAIN; INTRACAVERNOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIAPISM; PRIORITY JOURNAL; PSYCHOGENESIS; RETROSPECTIVE STUDY; SELF INJECTION;

EID: 0032436719     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900353     Document Type: Article

References (15)

1. Virag R. Intracavernous injection of Papaverine for erectile failure. Lancet 1982; ii: 938.
2. Ishii et al. Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence. J Urol 1989; 141: 323-325.
3. Schmidt CW Jr. Common male disorders: Impotence and premature ejaculation. In: Meyer JK, Schmidt, CW Jr, Wise TN, eds. Clinical Management of Sexual Disorders 2nd edn. Williams and Wilkins: Baltimore, 1983, pp 173-196.
4. Masters WH, Johnson VE, Kolodny RC. Sexual dysfunctions and sex therapy. In: Masters WH, Johnson VE, Kolodny RC, eds. Human Sexuality. 4th edn. Harper Collins: New York, 1992, pp 563-566.
5. Heyden BV, Donatucci, CF, Kaula N, Lue TF. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. J Urol 1993; 149: 1288-1290.
6. Hawton K, Catalan J, Fagg J. Sex therapy for erectile dysfunction: characteristics of couples, treatment outcome, and prognostic factors. Arch Sex Behav 1992; 21: 161-175.
7. Vickers MA Jr, De Nobrega AM, Dluhy RG. Diagnosis and treatment of psychological erectile dysfunction in a urological setting: outcomes of 18 consecutive cases. J Urol 1993; 149: 1258-1261.
8. Govier et al. Timing of penile color flow duplex ultrasonography using a triple drug mixture. J Urol 1995; 153: 1472-1475.
9. Chiou et al. Hemodynamic patterns of pharmacologically induced erection. Evaluation by order doppler sonography. J Urol 1998; 159: 109-112.
10. Sattar et al. Correlation of nocturnal penile tumescence monitoring, duplex ultrasonography and infusion cavernosometry for the diagnosis of erectile dysfunction. J Urol 1996; 155: 1274-1276.
11. Glina et al. Veno-occlusive dysfunction of the corpora cavernosa: comparison of diagnostic methods. Int J Impot Res 1995; 7: 1-10.
12. Lue TF. Impotence: a patient goal directed approach to treatment. World J Urol 1990; 8: 67-74.
13. Buvat J, Lemaire A. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and a cost effective strategy. J Urol 1997; 158: 1764-1767.
14. Baker W, Pfriman D. Volunteer bias and personality traits in sexual standards research. Arch Sex Behav 1973; 4: 161-171.
15. Catania JA, McDermott LJ, Pollack LM. Questionnaire response bias and face to face interview sample bias in sexuality research. J Sex Res 1986; 22: 52-72.